VJOncology is committed to improving our service to you

NCRI 2019 | HER-2 conversion: a phenomenon in trastuzumab resistance

VJOncology is committed to improving our service to you

Russell Petty

Russell Petty, BMSC, MB ChB, PhD, MRCP, University of Dundee, Dundee, UK, talks about precision cancer biology and the phenomenon of HER-2 conversion that occurs in trastuzumab resistance. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter